Adverse Reaction to Drug Clinical Trial
Official title:
Clinical Analysis of Safety in Latent Tuberculosis Infection Prophylaxis Treatment
The treatment of latent TB with 3HP is an important issue for the prevention of active TB. However, significant proportion of subjects receiving 3HP had adverse reaction. The main purpose of this observation study is to identify subjects who have higher risk to develop adverse reaction. Clinical characteristics and biomarker will be used to predict adverse reaction.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT01430702 -
Feasibility of Using a Telemedicine Medication Delivery Unit for Older Adults
|
N/A | |
| Active, not recruiting |
NCT01237275 -
Development of A Technique to Predict Antidepressant Responsiveness in Depressive Patients
|
N/A | |
| Terminated |
NCT02296840 -
Post-operative Pain Control After Pediatric Adenotonsillectomy
|
Phase 4 | |
| Terminated |
NCT01600677 -
Determining the Impact of a Medication Delivery Unit on Medication Adherence of Adults With Common Cardiac Conditions
|
N/A | |
| Recruiting |
NCT02353455 -
Cells of Monocytic Origin as Surrogate Markers for Individual Drug Effects and Hepatotoxicity
|
||
| Completed |
NCT02012712 -
Personal Health Records and Elder Medication Use Quality
|
N/A | |
| Completed |
NCT02609919 -
Assessment of Immediate Adverse Reactions From Dotarem in Children Under 2 Years of Age
|
||
| Completed |
NCT06124417 -
Efficacy and Safety of Sertraline in the Treatment of Maintenance Hemodialysis Patients With Depression
|
Phase 4 | |
| Recruiting |
NCT00817375 -
Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients
|
N/A | |
| Active, not recruiting |
NCT00935246 -
Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide Scanning
|
N/A | |
| Completed |
NCT04226443 -
The Use of Midazolam and Remifentanil During Dialysis Access Procedures
|
N/A | |
| Recruiting |
NCT02520570 -
Post-market Safety Reassessment of Ulinastatin for Injection
|
||
| Completed |
NCT01621373 -
Exploratory Propofol Dose Finding Study In Neonates
|
Phase 2 | |
| Completed |
NCT02447679 -
Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence
|
Phase 2 | |
| Recruiting |
NCT05645302 -
Intensive Monitoring Scheme of Lidocaine Cataplasms
|
||
| Enrolling by invitation |
NCT01830257 -
Explore Active Surveillance Mode of the Community's Adverse Event Following Immunization(AEFI)
|
Phase 4 | |
| Recruiting |
NCT01354197 -
The Thai Surgical Intensive Care Study (Thai-SICU Study)
|
N/A |